AMPK Activators as Novel Therapeutics for Type 2 Diabetes

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|10|4|397-410

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.10, Iss.4, 2010-03, pp. : 397-410

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glucokinase Activators for the Potential Treatment of Type 2 Diabetes

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 17, 2008-11 ,pp. : 1524-1532

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies for the design of hepatoselective glucokinase activators to treat type 2 diabetes

By Pfefferkorn Jeffrey A  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 3, 2013-03 ,pp. : 319-330

Informa Healthcare

Access to resources Recommend Favorite

Glucokinase activators as new type 2 diabetes therapeutic agents

By Sarabu Ramakanth   Berthel Steven J   Kester Robert F   Tilley Jefferson W  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 7, 2008-07 ,pp. : 759-768

Informa Healthcare

Access to resources Recommend Favorite

Recent Updates on Glucokinase Activators for the Treatment of Type 2 Diabetes Mellitus

By  

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 7, 2014-06 ,pp. : 585-602

Bentham Science Publishers

Access to resources Recommend Favorite

Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated Protein Kinase (AMPK) Activators

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 6, 2014-07 ,pp. : 778-785

Bentham Science Publishers

Access to resources Recommend Favorite